ReviewCureus2025
Psychological Well-Being in Breast Cancer: A Literature Review of the Impact of Precision Oncology and Radiogenomics.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.Breast cancer (Dove Medical Press) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiogenomic testing, including tools such as Oncotype DX, MammaPrint, and Prosigna, has transformed breast cancer management through improved risk stratification and personalized therapy. However, several potential psychological burdens can result as consequences for these genomic tools. This literature review includes 25 peer-reviewed studies published between 2015 and 2025 that examined the psychological outcomes associated with radiogenomic testing in breast cancer patients. Anxiety, depression, fear of recurrence, and decision conflict were the most common themes encountered in these studies, particularly among those receiving intermediate or high genomic risk scores. Additional moderation factors such as age, health literacy, socioeconomic status, and communication quality were also linked to variations in distress levels. Thematic analysis highlights the importance of integrating psychological support, patient education, and counseling throughout the genomic testing process. This review emphasizes the need for a holistic, patient-centered approach that addresses the emotional and cognitive consequences of precision oncology and identifies key areas for future psychosocial intervention research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.